Long-Term Control of Retinal Thickness Variability and Vision Following the 0.19 mg Fluocinolone Acetonide Implant. [PDF]
J Vitreoretin Dis, 2023 Sheth VS +6 more
europepmc +1 more source
The role of vitreous and vitreoretinal interface in the management of diabetic macular edema [PDF]
, 2022 Bernardete Bela dos Santos Teixeira Pessoa
core
Delayed-Onset Wound Leakage and Endophthalmitis After Intravitreal Implantation of Fluocinolone Acetonide. [PDF]
J Vitreoretin DisChang PS +6 more
europepmc +1 more source
Impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes. [PDF]
Eye (Lond)Kozak I +4 more
europepmc +1 more source
Clinical Application of Drug Delivery Systems for Treating AMD [PDF]
, 2012 Noriyuki Kuno, Shinobu Fujii
core +1 more source
Stabilizing Macular Edema Fluctuations: Outcomes of Intravitreal Fluocinolone Acetonide for Diabetic Macular Edema and Non-Infectious Uveitis. [PDF]
J Clin MedHohberger B +3 more
europepmc +1 more source
Handshake technique for removal of fluocinolone acetonide implant from the vitreous cavity. [PDF]
BMJ Case RepReddy RR, Pathak Ray V, Singh DV.
europepmc +1 more source
Ocular gene therapy as a sustained drug delivery system: pharmacokinetic and genokinetic perspectives. [PDF]
J Med LifeLeferman CE, Ciubotaru AD.
europepmc +1 more source
Intravitreal therapy for the management of diabetic retinopathy: A concise review. [PDF]
World J Exp MedArora A +5 more
europepmc +1 more source
Modulation of Oxidative Stress in Diabetic Retinopathy: Therapeutic Role of Natural Polyphenols. [PDF]
Antioxidants (Basel)Gómez-Jiménez V +2 more
europepmc +1 more source